Navigation Links
Biotrial, a Leading Provider of Drug Development Services, Has Completed its Acquisition of Warnex Bioanalytical Services Division

(PRWEB) February 22, 2013

The acquisition of the Warnex Bioanalytical Services division allows Biotrial to broaden its drug development services to its international clients, giving them access to the full spectrum of Bioanalytical services to support preclinical and clinical development, including generics product development. To complement the service offering, Warnex clients now have access to the large range of existing Biotrial drug development services.

The new Biotrial addition includes: a team of highly experienced experts including a staff of over 70, more than 250 validated assays, 25 000 sq. ft. cutting edge laboratories and work stations, over 20 Mass Spectrometers and a validated Watson® LIMS.

BBS services have a SCC certification; have been audited by the FDA and AGES regulatory agencies. Services offered include: method development & validation, preclinical, bioavailability and bioequivalence studies, as well as therapeutic drug monitoring.

Jean-Marc Gandon, Pharm.D., President & CEO of Biotrial, says: “We have been looking for many years to find the right partner to complement our offer with sample analysis so that our customers could benefit from a full package in their process of developing new drugs or generics. Because of its ability to meet the growing needs of the pharmaceutical industry and to use the latest technology Warnex became an obvious choice. Biotrial is committed to continue providing the excellent service and quality of science for which the Montreal site is known for, by continuing its investment in the latest state-of-the-art equipment.”

Michael Mancini, Ph.D., BBS Inc. President, affirms: “It has been a very smooth transition and we are particularly excited to officially be a part of the Biotrial team. There is no change in management or staff and for us it is ‘business as usual.’ Being a part of such an international and well recognized CRO ensures that we will continue to expand our service offering as we have been doing for so many years.”

With the Bioanalytical acquisition Biotrial continues its expansion into the North American market which, will be complemented by the opening of an additional Clinical Unit in New Jersey later this year.

About Biotrial
Founded in 1989, Biotrial is a leading CRO specialized in Early Development with a large range of services from Non-Clinical Pharmacology, Phase I studies, Phase II-IV Trial Management, Bioanalytical analysis, Oncology, Data Management, Biostatistics, ECG & Imaging Core Lab (QT/QTc Trials, Psychometric Testing, Imaging, EEG/PSG Assessment), Regulatory Affairs to Medical Writing.

Based in France, Belgium, the United Kingdom, Canada and the United States, Biotrial performs hundreds of studies a year and offers tailor-made solutions to Biotech and Pharmaceutical companies.

For further information please contact Anne Peron at [+33] (0)2 99 599 191 or visit [

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Plunketts Biotech & Genetics Industry Almanac 2013: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies
2. PROLOR Biotech To Present New Preclinical Data On Its Long-Acting Clotting Factor VIIa At Leading European Scientific Conference
3. ViaCytes Role as a Leading Cell Therapy Company Bolstered with the Issuance of 20 Patents in 2012
4. Agency Take-up Soars of Agnitios Leading Pull Marketing Platform for the Healthcare Industry
5. LATISTA Announces Next-Generation iPad App 2.0 for Construction with Industry Leading Innovations
6. The Leading Edge Of Medical Innovation: New Prenatal Genetic Tests Use Moms Blood To Learn About Her Baby
7. Crisalix Awarded as a Leading Life Science Company that is Revolutionizing the Medical Industry
8. Speech and Language Therapy Jobs and Biomedical Science Jobs - Medicspro Leading the way for Medical Recruitment Agencies in the UK
9. Japan Bioinformatics Announces Study on Leading Mapping Tools for DNA Mutation Discovery
10. A leading Massachusetts-based IT and Life Sciences staffing and consulting firm has opened two new offices in the Ohio Valley
11. Maker of leading in-home HIV test encourages testing
Post Your Comments:
(Date:10/12/2017)... ... 12, 2017 , ... DuPont Pioneer and recently formed CasZyme, ... into a multiyear collaboration to identify and characterize novel CRISPR-Cas nucleases. The goal ... editing across all applications. , Under the terms of the agreement, Pioneer will ...
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a global contract research, ... improve patient outcomes and quality of life, will now be offering its impurity ... to new regulatory requirements for all new drug products, including the finalization of ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... any gene in its endogenous context, enabling overexpression experiments and avoiding the use ... with small RNA guides is transformative for performing systematic gain-of-function studies. , ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., ... a Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. ... best practices and how Proscia improves lab economics and realizes an increase in ...
Breaking Biology Technology:
(Date:5/6/2017)... 2017 RAM Group , Singaporean ... breakthrough in biometric authentication based on a ... to perform biometric authentication. These new sensors are based ... by Ram Group and its partners. This sensor will ... chains and security. Ram Group is a next ...
(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
(Date:4/17/2017)... April 17, 2017 NXT-ID, Inc. (NASDAQ: ... the filing of its 2016 Annual Report on Form 10-K on ... ... is available in the Investor Relations section of the Company,s website ... SEC,s website at . 2016 Year Highlights: ...
Breaking Biology News(10 mins):